drugset / Trial / NCT04831151
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-03
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cyproterone acetate | Small molecule | 2 mg | Oral |
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.035 mg | Oral |